155 related articles for article (PubMed ID: 27785526)
1. Efficacy and safety of aspirin combined with warfarin after acute coronary syndrome : A meta-analysis.
Zhang P; Li J; Wu C; Huang X; Li L; Zhang W; Shen C
Herz; 2017 May; 42(3):295-306. PubMed ID: 27785526
[TBL] [Abstract][Full Text] [Related]
2. Should aspirin be continued in patients started on warfarin?
Larson RJ; Fisher ES
J Gen Intern Med; 2004 Aug; 19(8):879-86. PubMed ID: 15242475
[TBL] [Abstract][Full Text] [Related]
3. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results.
Anand SS; Yusuf S; Pogue J; Weitz JI; Flather M
Circulation; 1998 Sep; 98(11):1064-70. PubMed ID: 9736592
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment. A meta-analysis.
Chen CF; Chen B; Zhu J; Xu YZ
Herz; 2015 Dec; 40(8):1070-83. PubMed ID: 26135462
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Triple Therapy and Dual Therapy With Direct Oral Anticoagulants Compared to Warfarin.
Amano H; Saito D; Yabe T; Okubo R; Toda M; Ikeda T
Int Heart J; 2017 Aug; 58(4):570-576. PubMed ID: 28701676
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies.
Bavishi C; Koulova A; Bangalore S; Sawant A; Chatterjee S; Ather S; Valencia J; Sarafoff N; Rubboli A; Airaksinen JK; Lip GY; Tamis-Holland JE
Catheter Cardiovasc Interv; 2016 Jul; 88(1):E12-22. PubMed ID: 26354765
[TBL] [Abstract][Full Text] [Related]
7. Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit.
Rothberg MB; Celestin C; Fiore LD; Lawler E; Cook JR
Ann Intern Med; 2005 Aug; 143(4):241-50. PubMed ID: 16103468
[TBL] [Abstract][Full Text] [Related]
8. Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials.
Kumar G; Goyal MK
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1279-87. PubMed ID: 23182364
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.
Anand SS; Yusuf S
JAMA; 1999 Dec; 282(21):2058-67. PubMed ID: 10591389
[TBL] [Abstract][Full Text] [Related]
10. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial.
Alexander JH; Lopes RD; Thomas L; Alings M; Atar D; Aylward P; Goto S; Hanna M; Huber K; Husted S; Lewis BS; McMurray JJ; Pais P; Pouleur H; Steg PG; Verheugt FW; Wojdyla DM; Granger CB; Wallentin L
Eur Heart J; 2014 Jan; 35(4):224-32. PubMed ID: 24144788
[TBL] [Abstract][Full Text] [Related]
11. How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the UK General Practice Research Database.
Rietbrock S; Plumb JM; Gallagher AM; van Staa TP
Thromb Haemost; 2009 Mar; 101(3):527-34. PubMed ID: 19277415
[TBL] [Abstract][Full Text] [Related]
12. Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis.
Lee M; Saver JL; Hong KS; Wu HC; Ovbiagele B
Circ Heart Fail; 2013 Mar; 6(2):287-92. PubMed ID: 23264446
[TBL] [Abstract][Full Text] [Related]
13. Association of Adding Aspirin to Warfarin Therapy Without an Apparent Indication With Bleeding and Other Adverse Events.
Schaefer JK; Li Y; Gu X; Souphis NM; Haymart B; Kline-Rogers E; Almany SL; Kaatz S; Kozlowski JH; Krol GD; Sood SL; Froehlich JB; Barnes GD
JAMA Intern Med; 2019 Apr; 179(4):533-541. PubMed ID: 30830172
[TBL] [Abstract][Full Text] [Related]
14. The association between prior use of aspirin and/or warfarin and the in-hospital management and outcomes in patients presenting with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE).
Amad H; Yan AT; Yan RT; Huynh T; Gore JM; Montalescot G; DeYoung JP; Gallo R; Rose B; Steg PG; Goodman SG;
Can J Cardiol; 2012; 28(1):48-53. PubMed ID: 22112683
[TBL] [Abstract][Full Text] [Related]
15. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.
Testa L; Zoccai GB; Porto I; Trotta G; Agostoni P; Andreotti F; Crea F
Am J Cardiol; 2007 Jun; 99(12):1637-42. PubMed ID: 17560866
[TBL] [Abstract][Full Text] [Related]
16. Effects of warfarin, aspirin and the two combined, on mortality and thromboembolic morbidity after myocardial infarction. The WARIS-II (Warfarin-Aspirin Reinfarction Study) design.
Hurlen M; Smith P; Arnesen H
Scand Cardiovasc J; 2000; 34(2):168-71. PubMed ID: 10872704
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.
Wallentin L; Lopes RD; Hanna M; Thomas L; Hellkamp A; Nepal S; Hylek EM; Al-Khatib SM; Alexander JH; Alings M; Amerena J; Ansell J; Aylward P; Bartunek J; Commerford P; De Caterina R; Erol C; Harjola VP; Held C; Horowitz JD; Huber K; Husted S; Keltai M; Lanas F; Lisheng L; McMurray JJ; Oh BH; Rosenqvist M; Ruzyllo W; Steg PG; Vinereanu D; Xavier D; Granger CB;
Circulation; 2013 Jun; 127(22):2166-76. PubMed ID: 23640971
[TBL] [Abstract][Full Text] [Related]
18. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
[TBL] [Abstract][Full Text] [Related]
19. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.
Hylek EM; Held C; Alexander JH; Lopes RD; De Caterina R; Wojdyla DM; Huber K; Jansky P; Steg PG; Hanna M; Thomas L; Wallentin L; Granger CB
J Am Coll Cardiol; 2014 May; 63(20):2141-2147. PubMed ID: 24657685
[TBL] [Abstract][Full Text] [Related]
20. Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
Hess CN; Peterson ED; Peng SA; de Lemos JA; Fosbol EL; Thomas L; Bhatt DL; Saucedo JF; Wang TY
J Am Coll Cardiol; 2015 Aug; 66(6):616-27. PubMed ID: 26248987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
